Improving Crossmatch Techniques and Graft Outcomes.
作者信息
Vincent L
机构信息
Department of Nephrology, Narayana Health, Bengaluru, Karnataka, India.
出版信息
Indian J Nephrol. 2018 Nov-Dec;28(6):491-492. doi: 10.4103/ijn.IJN_362_17.
Abstract
摘要
相似文献
1
Improving Crossmatch Techniques and Graft Outcomes.
Indian J Nephrol. 2018 Nov-Dec;28(6):491-492. doi: 10.4103/ijn.IJN_362_17.
2
Influence of anti-HLA antibodies and positive T-lymphocytotoxic crossmatch on survival and graft rejection in human liver transplantation.
J Hepatol. 1996 Apr;24(4):452-9. doi: 10.1016/s0168-8278(96)80166-8.
3
The use of the kidney with an historical positive, and current negative crossmatch.
Pediatr Nephrol. 1991 Jan;5(1):126-9. doi: 10.1007/BF00852869.
4
Implications of a positive crossmatch in liver transplantation: a 20-year review.
Liver Transpl. 2012 Apr;18(4):455-60. doi: 10.1002/lt.22474.
5
Pancreas transplantation in crossmatch-positive recipients.
Clin Transplant. 2003 Jun;17(3):242-8. doi: 10.1034/j.1399-0012.2003.00042.x.
6
Positive pretransplant crossmatches predict early graft loss in liver allograft recipients.
Transplantation. 1994 Feb 27;57(4):616-20.
7
The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation.
Transpl Immunol. 1993;1(1):60-5. doi: 10.1016/0966-3274(93)90060-l.
8
Crossmatch tests--an analysis of UNOS data from 1991-2000.
Clin Transpl. 2001:237-46.
9
Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch.
Ann Surg. 1996 Aug;224(2):168-77. doi: 10.1097/00000658-199608000-00009.
10
Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation.
Transplantation. 2001 Apr 27;71(8):1163-8. doi: 10.1097/00007890-200104270-00025.
本文引用的文献
1
Rapid optimized flow cytometric crossmatch (FCXM) assays: The Halifax and Halifaster protocols.
Hum Immunol. 2018 Jan;79(1):28-38. doi: 10.1016/j.humimm.2017.10.020. Epub 2017 Nov 9.
2
Correlation of Pretransplant Donor-specific Antibody Assay Using Luminex Crossmatch with Graft Outcome in Renal Transplant Patients.
Indian J Nephrol. 2017 Sep-Oct;27(5):347-352. doi: 10.4103/ijn.IJN_132_16.
3
Complement-binding anti-HLA antibodies and kidney-allograft survival.
N Engl J Med. 2013 Sep 26;369(13):1215-26. doi: 10.1056/NEJMoa1302506.
4
Correlation between Luminex donor-specific crossmatches and levels of donor-specific antibodies in pretransplantation screening.
Tissue Antigens. 2013 Jul;82(1):16-20. doi: 10.1111/tan.12128. Epub 2013 Apr 29.
Zotero 插件